Peter C. Grayson

14.6k total citations · 11 hit papers
141 papers, 6.2k citations indexed

About

Peter C. Grayson is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Peter C. Grayson has authored 141 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Rheumatology, 82 papers in Pulmonary and Respiratory Medicine and 35 papers in Genetics. Recurrent topics in Peter C. Grayson's work include Vasculitis and related conditions (79 papers), Otitis Media and Relapsing Polychondritis (51 papers) and Vascular Anomalies and Treatments (20 papers). Peter C. Grayson is often cited by papers focused on Vasculitis and related conditions (79 papers), Otitis Media and Relapsing Polychondritis (51 papers) and Vascular Anomalies and Treatments (20 papers). Peter C. Grayson collaborates with scholars based in United States, United Kingdom and Portugal. Peter C. Grayson's co-authors include Peter A. Merkel, Michael P. LaValley, Hyon K. Choi, Seoyoung C. Kim, Mariana J. Kaplan, Mark A. Ahlman, Gunnar Tómasson, Raashid Luqmani, Ravi Suppiah and Joanna Robson and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Peter C. Grayson

135 papers receiving 6.1k citations

Hit Papers

Hyperuricemia and incident hypertension: A systematic rev... 2010 2026 2015 2020 2010 2022 2022 2022 2022 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hyperuricemia and incident hypertension: A systematic review and meta‐analysis
    2010 573 citations Peter C. Grayson, Michael P. LaValley et al. Arthritis Care & Research profile →
  2. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis
    2022 244 citations Peter C. Grayson, Cristina Ponte et al. Annals of the Rheumatic Diseases profile →
  3. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis
    2022 212 citations Joanna Robson, Peter C. Grayson et al. Annals of the Rheumatic Diseases profile →
  4. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis
    2022 176 citations Ravi Suppiah, Joanna Robson et al. Annals of the Rheumatic Diseases profile →
  5. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
    2022 150 citations Cristina Ponte, Peter C. Grayson et al. Annals of the Rheumatic Diseases profile →
  6. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1
    2021 139 citations Bhavisha A. Patel, Emma M. Groarke et al. Blood Advances profile →
  7. Large-vessel vasculitis
    2022 127 citations Dan Pugh, Neil Basu et al. Nature Reviews Disease Primers profile →
  8. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population
    2023 113 citations David B. Beck, Peter C. Grayson et al. profile →
  9. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis
    2022 111 citations Joanna Robson, Peter C. Grayson et al. Arthritis & Rheumatology profile →
  10. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis
    2022 110 citations Peter C. Grayson, Cristina Ponte et al. Arthritis & Rheumatology profile →
  11. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis
    2022 95 citations Ravi Suppiah, Joanna Robson et al. Arthritis & Rheumatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter C. Grayson United States 41 3.4k 2.7k 1.3k 1.1k 1.1k 141 6.2k
Kenneth J. Warrington United States 44 4.5k 1.3× 4.1k 1.5× 792 0.6× 1.6k 1.4× 1.4k 1.3× 254 7.7k
Rüdiger Waldherr Germany 38 4.4k 1.3× 1.7k 0.6× 1.4k 1.1× 998 0.9× 1.1k 1.0× 97 7.0k
Ingeborg M. Bajema Netherlands 51 3.4k 1.0× 2.6k 1.0× 1.6k 1.3× 2.5k 2.2× 1.4k 1.2× 181 9.7k
Franco Ferrario Italy 36 3.0k 0.9× 1.6k 0.6× 1.5k 1.2× 1.3k 1.1× 1.1k 1.0× 99 7.1k
Jan A. Bruijn Netherlands 44 2.8k 0.8× 1.7k 0.6× 1.8k 1.4× 1.7k 1.4× 897 0.8× 159 8.6k
John L. Niles United States 34 2.5k 0.7× 1.0k 0.4× 619 0.5× 735 0.6× 871 0.8× 85 3.8k
A. Mékinian France 38 1.2k 0.3× 1.4k 0.5× 478 0.4× 1.1k 1.0× 552 0.5× 231 4.4k
Marion Haubitz Germany 40 1.6k 0.5× 720 0.3× 1.3k 1.0× 768 0.7× 514 0.5× 119 4.7k
Carl Turesson Sweden 45 1.5k 0.5× 4.6k 1.7× 574 0.4× 1.2k 1.1× 593 0.5× 170 6.6k
Lynn D. Cornell United States 50 1.3k 0.4× 1.2k 0.4× 2.4k 1.8× 1.3k 1.2× 628 0.6× 144 7.7k

Countries citing papers authored by Peter C. Grayson

Since Specialization
Citations

This map shows the geographic impact of Peter C. Grayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Grayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Grayson more than expected).

Fields of papers citing papers by Peter C. Grayson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Grayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Grayson. The network helps show where Peter C. Grayson may publish in the future.

Co-authorship network of co-authors of Peter C. Grayson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Grayson. A scholar is included among the top collaborators of Peter C. Grayson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Grayson. Peter C. Grayson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomelleri, Alessandro, et al.. (2025). The Role of FDG-PET in the Diagnosis and Monitoring of Large-Vessel Vasculitis. Current Rheumatology Reports. 27(1). 40–40.
2.
Quinn, Kaitlin A., Mark A. Ahlman, & Peter C. Grayson. (2025). Use of 18F‐fluorodeoxyglucose Positron Emission Tomography to Monitor Disease Activity in Patients With Giant Cell Arteritis on Tocilizumab. ACR Open Rheumatology. 7(2). e11797–e11797. 1 indexed citations
3.
Sawalha, Amr H., Durga Prasanna Misra, Fatma Alıbaz-Öner, et al.. (2025). Advances in the pathophysiology, diagnosis and treatment of Takayasu arteritis. Nature Reviews Rheumatology. 21(12). 737–751.
4.
Chen, Simon, et al.. (2025). Rapid clinical deployment of UBA1 testing in patients with VEXAS syndrome. American Journal of Clinical Pathology. 164(3). 360–366.
5.
Rhee, Rennie L., Kaitlin A. Quinn, Naomi A. Amudala, et al.. (2025). Clinical Manifestations and Treatment in Patients With Relapsing Polychondritis: A Multicenter Observational Cohort Study. ACR Open Rheumatology. 7(5). e70027–e70027. 1 indexed citations
6.
Fanlo, P., et al.. (2023). Episcleritis and periorbital edema secondary to VEXAS syndrome. Archivos de la Sociedad Española de Oftalmología (English Edition). 98(10). 607–610. 6 indexed citations
7.
Ahlman, Mark A. & Peter C. Grayson. (2023). Advanced molecular imaging in large-vessel vasculitis: Adopting FDG-PET into a clinical workflow. Best Practice & Research Clinical Rheumatology. 37(1). 101856–101856. 7 indexed citations
8.
Marvisi, Chiara, Ertuğrul Çağrı Bölek, Mark A. Ahlman, et al.. (2023). Development of the Takayasu Arteritis Integrated Disease Activity Index. Arthritis Care & Research. 76(4). 531–540. 10 indexed citations
9.
Gutierrez‐Rodrigues, Fernanda, Kristina V Wells, Massimo Gadina, et al.. (2023). Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu’s arteritis, ANCA-associated vasculitis and giant cell arteritis. Annals of the Rheumatic Diseases. 83(4). 508–517. 14 indexed citations
10.
Ding, Yanna, Alina Dulau‐Florea, Emma M. Groarke, et al.. (2023). Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndrome. Blood Advances. 7(20). 6151–6155. 4 indexed citations
11.
Martín‐Nares, Eduardo, et al.. (2022). Orbital and periorbital inflammation in VEXAS syndrome. Scandinavian Journal of Rheumatology. 51(4). 338–341. 23 indexed citations
12.
Quinn, Kaitlin A., Mark A. Ahlman, Michael P. LaValley, et al.. (2022). Association of 18F‐Fluorodeoxyglucose–Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis. Arthritis & Rheumatology. 75(1). 98–107. 30 indexed citations
13.
Pugh, Dan, Neil Basu, María C. Cid, et al.. (2022). Large-vessel vasculitis. Nature Reviews Disease Primers. 7(1). 93–93. 127 indexed citations breakdown →
14.
Robson, Joanna, Peter C. Grayson, Cristina Ponte, et al.. (2022). 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Annals of the Rheumatic Diseases. 81(3). 315–320. 212 indexed citations breakdown →
15.
Quinn, Kaitlin A., Mark A. Ahlman, Elaine Novakovich, et al.. (2022). Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single‐Center Prospective Study. Arthritis Care & Research. 75(6). 1362–1370. 11 indexed citations
16.
Rose, Emily, Marcela A. Ferrada, Kaitlin A. Quinn, et al.. (2021). Physician Global Assessment as a Disease Activity Measure for Relapsing Polychondritis. Arthritis Care & Research. 74(8). 1269–1276. 5 indexed citations
17.
Robson, Joanna, Peter C. Grayson, Cristina Ponte, et al.. (2021). 2020 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. Annals of the Rheumatic Diseases. 1 indexed citations
18.
Morris, Michael, Peter C. Grayson, Michael T. Collins, et al.. (2021). Artificial Intelligence in Vascular-PET. PET Clinics. 17(1). 95–113. 9 indexed citations
19.
Michailidou, Despina, Joel S. Rosenblum, Casey A. Rimland, et al.. (2019). Clinical symptoms and associated vascular imaging findings in Takayasu's arteritis compared to giant cell arteritis. Annals of the Rheumatic Diseases. 79(2). 262–267. 29 indexed citations
20.
Banerjee, Shubhasree, Mohammadhadi Bagheri, Veit Sandfort, et al.. (2018). Vascular calcification in patients with large-vessel vasculitis compared to patients with hyperlipidemia. Seminars in Arthritis and Rheumatism. 48(6). 1068–1073. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth J. Warrington Breakdown of academic impact, for papers by Rüdiger Waldherr Breakdown of academic impact, for papers by Ingeborg M. Bajema Breakdown of academic impact, for papers by Franco Ferrario Breakdown of academic impact, for papers by Jan A. Bruijn Breakdown of academic impact, for papers by John L. Niles Breakdown of academic impact, for papers by A. Mékinian Breakdown of academic impact, for papers by Marion Haubitz Breakdown of academic impact, for papers by Carl Turesson Breakdown of academic impact, for papers by Lynn D. Cornell
Rankless by CCL
2026